Evolution of HIV dementia with HIV infection

References

• Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, et al. Variable progression of HIV-associated dementia. Neurology 1998; 50: 1814–1820
   PubMed Web of Science ®Google Scholar
• Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. Journal of Infectious Diseases 1997; 175: 963–966
   PubMed Web of Science ®Google Scholar
• Buchanan RJ, Wang S, Huang C. Nursing home residents with HIV and anemia. AIDS Patient Care STDS 2001; 15: 373–383
   PubMedGoogle Scholar
• Budka H. The definition of HIV-specific neuropathology. Acta Pathologica of Japan 1991; 41: 182–191
   PubMedGoogle Scholar
• Castellon SA, Hardy DJ, Hinkin CH, Satz P, Stenquist PK, van Gorp WG, et al. Components of depression in HIV-1 infection: Their differential relationship to neurocognitive performance. Journal of Clinical and Experimental Neuropsychology 2006; 28: 420–437
   PubMed Web of Science ®Google Scholar
• Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS 2004; 18(Suppl.1)S27–34
   PubMed Web of Science ®Google Scholar
• Clifford DB, Evans SR, Yang Y, Gulick RM. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS 2005; 19(Suppl.3)S64–71
   PubMed Web of Science ®Google Scholar
• Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy [Comments]. Nat Med 1998; 4: 1182–1184
   PubMed Web of Science ®Google Scholar
• DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447–454
   PubMed Web of Science ®Google Scholar
• Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 23: 1249–1253
   Google Scholar
• Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539–1545
   PubMed Web of Science ®Google Scholar
• Dube B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. Journal of Psychiatry Neurosci 2005; 30: 237–246
   PubMed Web of Science ®Google Scholar
• Ferrando SJ, Batki SL. Substance abuse and HIV infection. New Directions in Mental Health Service 2000; 57–67
   PubMedGoogle Scholar
• Flaskerud JH, Lee P. Vulnerability to health problems in female informal caregivers of persons with HIV/AIDS and age-related dementias. Journal of Adv Nurs 2001; 33: 60–68
   PubMed Web of Science ®Google Scholar
• Gelman BB, Schuenke K. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. Journal of Neurovirology 2004; 10: 98–108
   PubMed Web of Science ®Google Scholar
• Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Medicine 2006; 7: 112–121
   PubMed Web of Science ®Google Scholar
• Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 2005; 19: 407–411
   PubMed Web of Science ®Google Scholar
• Hersh LB. Peptidases, proteases and amyloid beta-peptide catabolism. Current Pharm Des 2003; 9: 449–454
   PubMedGoogle Scholar
• Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association 2001; 285: 1466–1474
   PubMed Web of Science ®Google Scholar
• Inungu JN, Mokotoff ED, Kent JB. Characteristics of HIV infection in patients fifty years or older in Michigan. AIDS Patient Care STDS 2001; 15: 567–573
   PubMed Web of Science ®Google Scholar
• Janssen ES. Nomenclature and research case definitions for neurologic manifestations of the human immunodeficiency virus-type 1 infection. Neurology 1991; 41: 778–785
   PubMedGoogle Scholar
• Kissel EC, Pukay-Martin ND, Bornstein RA. The relationship between age and cognitive function in HIV-infected men. Journal of Neuropsychiatry Clinical Neuroscience 2005; 17: 180–184
   PubMed Web of Science ®Google Scholar
• Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, et al. Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology 2002; 37: 349–354
   PubMed Web of Science ®Google Scholar
• Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. Aids 2002; 16: 1019–1029
   PubMed Web of Science ®Google Scholar
• Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. Aids 2005; 19(Suppl.3)S140–144
   PubMedGoogle Scholar
• Letendre SC, Ellis M, Marcotte R, Headton T, McCutchan J. A. R, Grant I. Individuals co-infected with hepatitis C (HCV) and HIV are more cognitive impaired than those infected with either virus alone. Presentation at 4th International Symposium on NeuroVirology and 10th Conference on Neuroscience of HIV Infection. 2002
   Google Scholar
• Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS 2005; 19(Suppl.3)S72–78
   PubMed Web of Science ®Google Scholar
• Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, et al. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000; 6: 1380–1387
   PubMed Web of Science ®Google Scholar
• Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, et al. A multimodal assessment of driving performance in HIV infection. Neurology 2004; 63: 1417–1422
   PubMed Web of Science ®Google Scholar
• Marder. DANA consortium on therapy for HIV dementia and related cognitive disorders 1996 (DANA Cohort). Journal of Neurovirology 1998
   Google Scholar
• Marine-Barjoan E, Saint-Paul MC, Pradier C, Chaillou S, Anty R, Michiels JF, et al. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS 2004; 18: 2163–2170
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 1993; 43: 176–182
   PubMed Web of Science ®Google Scholar
• McArthur JC. HIV dementia: An evolving disease. Journal of Neuroimmunology 2004; 157: 3–10
   PubMed Web of Science ®Google Scholar
• McArthur JC, Becker PS, Parisi JE, Trapp B, Selnes OA, Bornblath DR, et al. Neuropathological changes in early HIV-1 dementia. Annals of Neurology 1989; 26: 681–684
   PubMed Web of Science ®Google Scholar
• McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurology 2005; 4: 543–555
   PubMed Web of Science ®Google Scholar
• McArthur JC, McClernon DR, Cronin MF, Nance-Sproson EE, Saah AJ, St Clair M, et al. Relationship between human immunodeficiency virus associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology 1997; 42: 689–698
   PubMed Web of Science ®Google Scholar
• McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004; 61: 1687–1696
   PubMedGoogle Scholar
• McArthur JC, Sacktor N, Selnes O. Human Immunodeficiency Virus- associated dementia. Sem Neurol 1999; 19: 129–150
   PubMed Web of Science ®Google Scholar
• Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, et al. Cerebral CD8 + lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol (Berl) 2004; 108: 17–23
   PubMed Web of Science ®Google Scholar
• Nath A, Maragos W, Avison M, Schmitt F, Berger J. Accelerated HIV dementia with methamphetamine and cocaine use. Journal of Neurovirology 2001; 7: 66–71
   PubMed Web of Science ®Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Annals of Neurology 1986; 19: 517–524
   PubMed Web of Science ®Google Scholar
• Rabkin JG, McElhiney MC, Ferrando SJ. Mood and substance use disorders in older adults with HIV/AIDS: Methodological issues and preliminary evidence. AIDS 2004; 18(Suppl.1)S43–48
   PubMedGoogle Scholar
• Rackstraw S, Meadway J, Bingham J, Al-Sarraj S, Everall I. An emerging severe leukoencephalopathy: Is it due to HIV disease or highly active antiretroviral therapy?. International Journal of STD AIDS 2006; 17: 205–207
   PubMedGoogle Scholar
• Rempel HC, Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 2005; 19: 127–135
   PubMedGoogle Scholar
• Riedel DJ, Pardo CA, McArthur J, Nath A. Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol 2006; 2: 557–565
   PubMedGoogle Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neuroviroogyl 2002; 8: 136–142
   PubMed Web of Science ®Google Scholar
• Selnes OA. Memory loss in persons with HIV/AIDS: Assessment and strategies for coping. AIDS Read 2005; 15: 289–292, 294
   PubMedGoogle Scholar
• Selnes OA, McArthur JC, Royal WD, Updike ML, Nance-Sproson T, et al. HIV-1 infection and intravenous drug use: Longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992; 42: 1924–1930
   PubMed Web of Science ®Google Scholar
• Selnes OA, Miller E, McArthur J, Gordon B, Munoz A, Sheridan K, et al. HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology 1990; 40: 204–208
   PubMed Web of Science ®Google Scholar
• Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Disease 2002; 34: 831–837
   PubMed Web of Science ®Google Scholar
• Stoff DM. Mental health research in HIV/AIDS and aging: Problems and prospects. Aids 2004; 18(Suppl 1)S3–10
   PubMedGoogle Scholar
• Stoll M, Schmidt RE. Immune restoration inflammatory syndromes: Apparently paradoxical clinical events after the initiation of HAART. Current HIV/AIDS Rep 2004; 1: 122–127
   PubMedGoogle Scholar
• Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, et al. Higher frequency of dementia in older HIV-1 individuals: The Hawaii Aging with HIV-1 Cohort. Neurology 2004; 63: 822–827
   PubMed Web of Science ®Google Scholar
• van Asten L, Prins M. Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression. AIDS 2004; 18: 2319–2324
   PubMedGoogle Scholar
• Van Gorp WG, Lamb DG, Schmitt FA. Methodologic issues in neuropsychological research with HIV-spectrum disease. Archives of Clinical Neuropsychology 1993; 8: 17–33
   PubMed Web of Science ®Google Scholar
• Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV infected patients. Neurology 2006, in press
   Google Scholar
• Walsh DM, Selkoe DJ. Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 2004; 11: 213–228
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology 2004; 41: 845–851
   PubMed Web of Science ®Google Scholar
• Woody GE, Donnell D, Seage GR, Metzger D, Marmor M, Koblin BA, et al. Non-injection substance use correlates with risky sex among men having sex with men: Data from HIVNET. Drug Alcohol Depend 1999; 53: 197–205
   PubMed Web of Science ®Google Scholar